Unknown PHASE4 INTERVENTIONAL 2-arm NCT02094066

The Effect of Tranexamic Acid for Total Hip Arthroplasty

The Effects of High Doze Tranexamic Acid Application on Hemorrhage, Blood Transfusion, Fibrin Degradation Products, and Kidney Functions for Total Hip Arthroplasty

Sponsor: TC Erciyes University

Conditions Hemorrhage

Interventions serum physiologic tranexamic acid

Updated 6 times since 2017 Last updated: Mar 24, 2014 Started: Mar 31, 2014 Primary completion: Jun 30, 2014 Completion: Jul 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Hemorrhage and is currently ongoing. TC Erciyes University leads this study, which shows 6 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

TC Erciyes University

Data source: TC Erciyes University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kayseri, Turkey (Türkiye)